EXCLUSIVE: EMA to Assess SII Production Site Before Covishield Approval, Says No Role in Nod to EU Travel
EXCLUSIVE: EMA to Assess SII Production Site Before Covishield Approval, Says No Role in Nod to EU Travel News18 13 hours ago Aman Sharma © Provided by News18 EXCLUSIVE: EMA to Assess SII Production Site Before Covishield Approval, Says No Role in Nod to EU Travel The European Medicines Agency (EMA) would assess the manufacturing sites of Pune-based Serum Institute of India (SII) and its production processes as per the European Union (EU) law before approving the Covishield vaccine. The EMA has also made it clear that an approval for Vaxzevria vaccine does not mean an app...